60 Day FRN

53252

Federal Register / Vol. 83, No. 204 / Monday, October 22, 2018 / Notices

in writing to the contact person listed
above. All requests must contain the
name, address, telephone number, and
organizational affiliation of the
presenter. Written comments should not
exceed five single-spaced typed pages in
length and must be received by
November 19, 2018. Agenda items are
subject to change as priorities dictate.
The Chief Operating Officer, Centers
for Disease Control and Prevention, has
been delegated the authority to sign
Federal Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Sherri Berger,
Chief Operating Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2018–22987 Filed 10–19–18; 8:45 am]
BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-19–1014; Docket No. CDC–2018–
0096]

Proposed Data Collection Submitted
for Public Comment and
Recommendations
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice with comment period.
AGENCY:

The Centers for Disease
Control and Prevention (CDC), as part of
its continuing effort to reduce public
burden and maximize the utility of
government information, invites the
general public and other Federal
agencies the opportunity to comment on
a proposed and/or continuing
information collection, as required by
the Paperwork Reduction Act of 1995.
This notice invites comment on a
proposed information collection project
titled CDC Worksite Health Scorecard,
an updated organizational assessment
and planning tool designed to help
employers identify gaps in their health
promotion programs and prioritize highimpact strategies for health promotion at
their worksites.
DATES: CDC must receive written
comments on or before December 21,
2018.

daltland on DSKBBV9HB2PROD with NOTICES

SUMMARY:

You may submit comments,
identified by Docket No. CDC–2018–
0096 by any of the following methods:

ADDRESSES:

VerDate Sep<11>2014

18:12 Oct 19, 2018

Jkt 247001

• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Jeffrey M. Zirger, Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE, MS–D74, Atlanta,
Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. CDC will post, without
change, all relevant comments to
Regulations.gov.
Please note: Submit all comments
through the Federal eRulemaking portal
(regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the information collection plan and
instruments, contact Jeffrey M. Zirger,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS–
D74, Atlanta, Georgia 30329; phone:
404–639–7570; Email: [email protected].
SUPPLEMENTARY INFORMATION: Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide a
60-day notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to the OMB for approval. To
comply with this requirement, we are
publishing this notice of a proposed
data collection as described below.
The OMB is particularly interested in
comments that will help:
1. Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
2. Evaluate the accuracy of the
agency’s estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
3. Enhance the quality, utility, and
clarity of the information to be
collected; and
4. Minimize the burden of the
collection of information on those who
are to respond, including through the
use of appropriate automated,
electronic, mechanical, or other

PO 00000

Frm 00047

Fmt 4703

Sfmt 4703

technological collection techniques or
other forms of information technology,
e.g., permitting electronic submissions
of responses.
5. Assess information collection costs.
Proposed Project
CDC Worksite Health ScoreCard—
Revision—(OMB# 0920–1014 Exp.
02/28/2019) National Center for Chronic
Disease Prevention and Health
Promotion (NCCDPHP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In the United States, chronic diseases
such as heart disease, obesity and
diabetes are among the leading causes of
death and disability. Although chronic
diseases are among the most common
and costly health problems, they are
also among the most preventable.
Adopting healthy behaviors—such as
eating nutritious foods, being physically
active and avoiding tobacco use—can
prevent the devastating effects and
reduce the rates of these diseases.
Employers are recognizing the role
they can play in creating healthy work
environments and providing employees
with opportunities to make healthy
lifestyle choices. To support these
efforts, the Centers for Disease Control
and Prevention (CDC) developed an
online organizational assessment tool
called the CDC Worksite Health
Scorecard (‘‘Scorecard’’).
The Scorecard is a tool designed to
help employers assess whether they
have implemented evidence-based
health promotion interventions or
strategies in their worksites to prevent
heart disease, stroke, and related
conditions such as hypertension,
diabetes, and obesity. The updated,
validated, and pilot tested instrument
contains 154 core health topic yes/no
questions, eight core worksite
demographic questions, with an
additional eight optional worksite
demographic questions divided into 19
modules (risk factors/conditions/
demographics) that assess how
evidence-based health promotion
strategies are implemented at a
worksite. These strategies include
health promoting counseling services,
environmental supports, policies, health
plan benefits, and other worksite
programs shown to be effective in
preventing heart disease, stroke, and
related health conditions. Employers
can use this tool to assess how a
comprehensive health promotion and
disease prevention program is offered to
their employees, to help identify
program gaps, and to prioritize high
impact strategies for health promotion at
the worksite.

E:\FR\FM\22OCN1.SGM

22OCN1

53253

Federal Register / Vol. 83, No. 204 / Monday, October 22, 2018 / Notices
This is a revised Information
Collection Request (ICR) supporting a
broader group of employers to access
the updated and pilot tested Scorecard,
a web-based worksite organizational
assessment, to regularly assess their
workplace health programs and
practices. Scorecard users will create a
user account, complete the online
assessment and receive an immediate
feedback report that summarizes the
current status of their worksite health
program; identifies gaps in current
programming; benchmarks individual
employer results against other users of
the system; and provides access to
worksite health tools and resources to
address employer gaps and priority
program areas.

of the strategies and interventions
contained in the questions has been
completed. This will streamline future
information collection and minimize
additional response time.
CDC will continue to provide
outreach to, and register approximately
800 employers per year to use the online
Scorecard survey in their workplace
health program assessment, planning,
and implementation efforts, which is
open to employers of all sizes, industry
sectors, and geographic locations across
the country. OMB approval is requested
for three years. Participation is
voluntary and there are no costs to
respondents other than their time.

The updated Scorecard is based on a
2017 pilot test to determine the validity
and reliability involving 89 employers
(each represented by two knowledgeable
employees) who completed the survey
and follow-up telephone interviews to
gather general impressions of the
Scorecard—particularly the new
modules—and also to discuss items
where there were discrepancies (and
items that were left blank) to understand
the respondent’s interpretation and
perspective of their answers to these
questions. The revised instrument
includes some reorganization of the
instrument and minor revisions,
particularly to the new modules/
questions, to better explain and define
the context, concepts, or administration

ESTIMATED ANNUALIZED BURDEN HOURS
Average
burden per
response
(in hrs)

Total burden
(in hrs)

Form name

Employers .........................................

CDC Worksite Health ScoreCard
Registration.
CDC Worksite Health Scorecard .....

800

1

5/60

67

800

1

45/60

600

...........................................................

........................

........................

........................

667

Total ...........................................

Jeffrey M. Zirger,
Acting Chief, Information Collection Review
Office, Office of Scientific Integrity, Office
of the Associate Director for Science, Office
of the Director, Centers for Disease Control
and Prevention.

Department of Health and
Human Services (HHS), Centers for
Disease Control and Prevention (CDC).
ACTION: Notice of availability.

to include the footnotes to identify
clinics selected by CDC to participate in
the validation process of the National
ART Surveillance System (NASS) data
and: (a) Do participate, (b) do participate
and have major data discrepancies
identified through this process, or (c)
decline to participate in the data
validation process. This notice responds
to the comments received in response to
the notice published on May 31, 2018
and announces the availability of the
revised process for ART Success Rates
Reporting and plans for revising Data
Validation Procedures.
FOR FURTHER INFORMATION CONTACT:
Jeani Chang, Division of Reproductive
Health, National Center for Chronic
Disease Prevention and Health
Promotion, Centers for Disease Control
and Prevention, 4770 Buford Highway
NE, Mailstop F–74, Atlanta, Georgia
30341. Telephone: (770) 488–5200;
email: [email protected].

On May 31, 2018, the Centers
for Disease Control and Prevention
(CDC) in the Department of Health and
Human Services (HHS) requested
comments on a plan to (1) revise the
definition and characterization of
Assisted Reproductive Technology
(ART) success rates and (2) introduce
clinic validation footnotes for the
annual ART Fertility Clinic Success
Rates Report. In the plan, CDC proposed

Public Comment Summary and
Responses
CDC received three public comments
to the docket. One comment was
considered nonsubstantive because it
was outside the scope of the docket. A
second comment was supportive of
CDC’s planned approach for revising the
definition of success rates and
introducing clinic validation footnotes.
The third comment contained concerns

[FR Doc. 2018–22940 Filed 10–19–18; 8:45 am]
BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2018–0054]

Assisted Reproductive Technology
(ART) Success Rates Reporting and
Data Validation Procedures
AGENCY:

SUMMARY:

daltland on DSKBBV9HB2PROD with NOTICES

Number of
responses per
respondent

Number of
respondents

Type of respondent

VerDate Sep<11>2014

18:12 Oct 19, 2018

Jkt 247001

PO 00000

Frm 00048

Fmt 4703

Sfmt 4703

about CDC’s planned clinic validation
footnotes and the approach to clinic
validation, and requested a clarification
of the reporting requirements of embryo
banking cycles. These suggestions, as
well as CDC’s responses, are included
below:
1. ART success rates reporting: One
commenter asked that CDC provide
more details about reporting
requirements of embryo banking cycles.
Response: CDC thanks the commenter
for this request. Egg/embryo banking
cycles intended for pregnancy in the
short term include cycles initiated with
the intent of cryopreserving all eggs/
embryos for subsequent transfers within
12 months. Egg/embryo banking cycles
intended for pregnancy in the long term
(often referred to as fertility
preservation) include cycles where the
patient did not start any transfer cycles
within the 12 month period following
the date on which the intended retrieval
cycle started and one of the following:
(1) The cycle intent was long term (>12
months) banking for fertility
preservation prior to gonadotoxic
medical treatments; or (2) The cycle
intent was long term (>12 months)
banking for other reasons and (a) at least
one egg was retrieved, and (b) at least
one egg or embryo was frozen. Specifics
about the reporting process and
requirements are described in
‘‘Reporting of Pregnancy Success Rates

E:\FR\FM\22OCN1.SGM

22OCN1